94 results on '"Casado, M.Á."'
Search Results
2. Systematic review of the evidence on the epidemiology of herpes zoster: incidence in the general population and specific subpopulations in Spain
3. Local plant responses to global problems: Dactylis glomerata responses to different traffic pollutants on roadsides
4. The Cost of Psoriasis and Psoriatic Arthritis in 5 European Countries: A Systematic Review
5. Coste de la psoriasis y artritis psoriásica en cinco países de Europa: una revisión sistemática
6. Bilateral serous retinal detachments associated with IgA nephropathy
7. Desprendimientos de retina serosos bilaterales asociados a glomerulonefritis primaria por depósito de Inmunoglobulina A
8. Mental Health Self-Assessment in Patients With Moderate to Severe Psoriasis: An Observational, Multicenter Study of 1164 Patients in Spain (The VACAP Study)
9. Demographic characteristics and health-related quality of life of patients with moderate-to-severe psoriasis: The VACAP study
10. Los costes del ictus en España según su etiología. El protocolo del estudio CONOCES
11. Análisis de costes de tres candinas en el tratamiento de la candidiasis invasora en pacientes adultos no neutropénicos en España
12. Coste-utilidad de la incorporación de las nuevas vacunas antineumocócicas conjugadas al programa de vacunación de la comunidad de Madrid. Impacto sobre la enfermedad neumocócica invasora
13. Grassland productivity and diversity on a tree cover gradient in Nothofagus pumilio in NW Patagonia
14. A multi-stakeholder multicriteria decision analysis for the reimbursement of orphan drugs (FinMHU-MCDA study)
15. PMS21 Cost Analysis of Work and Household Productivity Improvements with Certolizumab Pegol in Patients with NON-Radiographic Axial Spondyloarthritis in Spain
16. PGI16 COST-EFFECTIVENESS OF TOFACITINIB FOR THE TREATMENT OF MODERATE-TO-SEVERE ULCERATIVE COLITIS AFTER BIOLOGIC FAILURE OR INTOLERANCE IN SPAIN
17. PSS8 EXTENDED LOADING DOSE OF ANTI-VEGF TREATMENT IN DIABETIC MACULAR EDEMA PATIENTS: A COST-CONSEQUENCE ANALYSIS
18. PMU23 COST OF ILLNESS IN PATIENTS WITH PSORIASIS AND PSORIATIC ARTHRITIS DISEASE. COEPSO STUDY
19. PGI17 COST-EFFECTIVENESS OF TOFACTINIB FOR THE TREATMENT OF MODERATE-TO-SEVERE ULCERATIVE COLITIS AFTER CONVENTIONAL THERAPY IN SPAIN
20. PMH70 DIRECT HEALTHCARE COSTS FOR THE MANAGEMENT OF PATIENTS WITH OPIOID USE DISORDER TREATED WITH METHADONE AND BUPRENORPHINE/NALOXONE IN REAL-WORLD SETTING IN SPAIN. COSTEDOPIA STUDY
21. PIN57 ECONOMIC EVALUATION OF AN ELECTRONIC HEALTH RECORD ALERT BY AGE IN PRIMARY CARE FOR THE DETECTION OF PATIENTS WITH CHRONIC HEPATITIS C
22. Tenofovir vs lamivudine plus adefovir in chronic hepatitis B: TENOSIMP-B study
23. Efficacy of Abiraterone acetate plus Prednisone and Enzalutamide sequences in men with metastatic castration-resistant prostate cancer: Systematic review and meta-analysis
24. PSS45 - A MULTI-STAKEHOLDER MULTICRITERIA DECISION ANALYSIS IN DIABETIC MACULAR EDEMA. MULTIDEX-EMD STUDY.
25. PMD120 - HEALTHCARE OUTCOMES OF ONE-STEP DIAGNOSIS IN PATIENTS WITH CHRONIC HEPATITIS C
26. PIN39 - IS THE UNIVERSAL POPULATION HEPATITIS C VIRUS SCREENING A COST-EFFECTIVE STRATEGY? A SYSTEMATIC REVIEW OF THE ECONOMIC EVIDENCE
27. PIN38 - CLINICAL AND ECONOMIC IMPACT OF THE TREATMENT OF CHRONIC HEPATITIS C IN PRISON INMATES IN SPAIN
28. PRO96 A Multi-Stakeholder Multicriteria Decision Analysis in Rare Diseases: Reimbursement Criteria for Orphan Drugs in Spain (FinMHU-MCDA study)
29. PIN97 Achieving 2030 Unaids Goals in Human Immunodeficiency VIRUS Individuals: A Simulation MODEL to Prioritize Interventions for Decision Making
30. PIN42 Economic- and Outcomes-Related VALUE of Sofosbuvir-Based Regimens for Chronic Hepatitis C in Spain
31. PSS17 EXTENDED MULTICRITERIA DECISION ANALYSIS IN DIABETIC MACULAR EDEMA. MULTIDEX-EMD EXTENSION STUDY
32. The use of prophylactic strategies using hepatitis B immunoglobulin for hepatitis B recurrence after liver transplantation in routine clinical practice in Spain. Preliminary results of the 1st round of a delphi panel
33. Cost-Effectiveness Analysis of Hepatitis B Virus Screening to Prevent Hepatitis B Virus Reactivation in Patients Receiving Rituximab Based Chemotherapy for Hematologic Malignancy
34. P0869 : Early versus delayed use of sofosbuvir plus peginterferon/ribavirin therapy in fibrosis patients with hepatitis C virus: A cost-effectiveness analysis
35. Economic Impact Linked To the Reduction of Exacerbations When A Treatment Regime With Inhaled Antibiotics Is Switched To Aztreonam Lysine In Patients With Cystic Fibrosis and Chronic Pulmonary Infection Caused By Pseudomonas Aeruginosa
36. Colaboradores
37. Costs in Patients Along First Year Poststroke in Spain
38. FRI-131 - Cost-Effectiveness Analysis of Hepatitis B Virus Screening to Prevent Hepatitis B Virus Reactivation in Patients Receiving Rituximab Based Chemotherapy for Hematologic Malignancy
39. The costs of stroke in Spain by aetiology: The CONOCES study protocol
40. Utilidad de la gammagrafía con hematíes marcados en el síndrome de Blue Rubber Bleb Nevus
41. PSY29 - Economic Impact Linked To the Reduction of Exacerbations When A Treatment Regime With Inhaled Antibiotics Is Switched To Aztreonam Lysine In Patients With Cystic Fibrosis and Chronic Pulmonary Infection Caused By Pseudomonas Aeruginosa
42. PRM30 - Future Costs Inclusion in Published Economic Evaluations: What Is the Current Situation?
43. PCV61 - Costs in Patients Along First Year Poststroke in Spain
44. PCN78 - Cost Assessment of Metastatic and Non-Metastatic Castration-Resistant Prostate Cancer Patient-Management in Spain
45. PSY16 - Cost Analysis of Bypassing Agent Prophylaxis Treatment Versus On-Demand Therapy in Hemophilia a with Inhibitor in Spain
46. PRS36 - Cost-Effectiveness Analysis of Glycopyrronium Bromide in the Treatment of Chronic Obstructive Pulmonary Disease in Spain
47. PND30 Cost Analysis of Glatiramer Acetate Versus Fingolimod for the Treatment of Patients With Relapsing-Remitting Multiple Sclerosis in Spain
48. PCV29 Health Care Resource Utilization and Costs of Cardioembolic Stroke in the Region of Madrid, Spain: Preliminary Results of CODICE Study
49. PCN72 Cost - Effectiveness Analysis of Cervical Cancer Vaccination Strategies in Spain
50. PCV61 are Hospital Costs for Stroke Underestimated in Spain?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.